Sertraline Hydrochloride is a selective serotonin reuptake inhibitor (SSRI) indicated for major depressive disorder, obsessive-compulsive disorder, panic disorder, PTSD and social anxiety disorder. We supply it to US manufacturers of tablets and oral concentrate.
Data from PubChem (CID 63009) and FDA’s substance registry
CAS number
79559-97-0
Molecular formula
C17H18Cl3N
Molecular weight
342.7g/mol
FDA UNII
IUPAC name
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine;hydrochloride
InChIKey
BLFQGGGGFNSJKA-XHXSRVRCSA-N
- Appearance
- White or off-white crystalline powder.
- Solubility
- Slightly soluble in water and isopropyl alcohol, and sparingly soluble in ethanol.
Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.
Worth settling with your inquiry
A secondary amine, so the nitrosamine assessment has to address N-nitroso-sertraline as well as the small nitrosamines. State the polymorphic form too.
On the US market
- Reference product
- ZoloftNDA 019839
- Approved ANDAs
- 21 with a marketed product
- Approved forms and strengths
- Tablet 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg
- Capsule 150 mg, 200 mg
- Oral concentrate 20 mg/mL
Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. Strengths of salt forms are stated as the active moiety. The brand name belongs to its owner and identifies the reference product only.
Grade
USP or Ph. Eur. where a monograph exists, or your own specification.
Quantities
From development quantities for formulation work to commercial supply.
Packaging
To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.
Regulatory filings
US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.
Documents available with a quote
- Specification and certificate of analysis
- Safety data sheet
- Method of analysis
- DMF letter of authorization, where a US DMF is filed
- GMP certificate and inspection history of the site
- Residual solvents and elemental impurities statements
- Nitrosamine risk assessment
- TSE/BSE statement
Need something else for your QA file? Email info@yogpharma.com
Escitalopram Oxalate
Selective serotonin reuptake inhibitor (SSRI)
CAS 219861-08-2Duloxetine Hydrochloride
Serotonin-norepinephrine reuptake inhibitor (SNRI)
CAS 136434-34-9Bupropion Hydrochloride
Norepinephrine-dopamine reuptake inhibitor
CAS 31677-93-7Trazodone Hydrochloride
Serotonin antagonist and reuptake inhibitor
CAS 25332-39-2